Protease inhibitor plasma concentrations associate with COVID-19 infection. (2021)

First Author: Medjeral-Thomas NR
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/oxfimm/iqab014

PubMed Identifier: 34458849

Publication URI: http://europepmc.org/abstract/MED/34458849

Type: Journal Article/Review

Volume: 2

Parent Publication: Oxford open immunology

Issue: 1

ISSN: 2633-6960